References Porter, L
50 (Fig
June 2024: The honorable Karen Spencer Marston is appointed to preside over the GLP-1 receptor agonist cases consolidated into an MDL out of the Eastern District of Pennsylvania
The studies being presented at this years meeting highlight how essential carefully designed trials are for evaluating new therapies, refining existing approaches, and ensuring that advances in science translate into safer, more effective care for people living with diabetes, she concluded
The most common adverse effects (AEs) associated with GBTs are GI, mainly nausea, vomiting, diarrhoea and constipation [22,23]
Symptoms include trembling, sweating, rapid heartbeat, anxiety, confusion, and difficulty concentrating